Projeto
Isolation and Purification of Plasmid DNA for Cancer Therapy [PTDC/EBB-BIO/114320/2009]
| Referência: | PTDC/EBB-BIO/114320/2009 |
|---|---|
| Programa de financiamento: | 5876-PPCDTI |
| Organização financiadora: | Fundação para a Ciência e a Tecnologia |
| Instituições associadas: | Universidade da Beira Interior |
Registos relacionados
Affinity purification and cell-specific delivery of a p53-encoding plasmid DNA for gene mediated cancer therapy
Bolsa de Doutoramento FCT: Novel affinity chromatography processes for the purification of plasmid DNA using small antibiotic molecules [SFRH/BD/64918/2009]
User-friendly model to simulate single and multi-component biomacromolecule adsorption onto ion-exchange and hydrophobic interaction supports [PTDC/EBB-BIO/113576/2009]
Bolsa de Doutoramento FCT: Mitochondrial Gene Therapy: Development of a mitochondrial targeted peptide/plasmid DNA vector [SFRH/BD/148393/2019]
PureDNA: Development of cost-effective platforms based on ionic liquids for the purification of p53-minicircle DNA biopharmaceuticals with application in oncology [2022.03394.PTDC]
Platform for the biosynthesis and purification of HPV-16 E6/E7mutant DNA vaccine for cervical cancer treatment or prevention
Bolsa de Doutoramento FCT: Cancer theragnostics-multifunctional gold nanoparticles for diagnostics and therapy [SFRH/BD/62957/2009]
MAGnetoLIposomes for DUal cancer therapy [PTDC/QUI-QFI/28020/2017]
Bolsa de Doutoramento FCT: Biosynthesis and purification of minicircle DNA for application in diabetes cell-specific gene therapy [SFRH/BD/80402/2011]
Bio-inspired deposition of a biomineral on biopolymers and on biopolymer/siloxane hybrids for biomedical applications [PTDC/CTM-BPC/112774/2009]
Skin2Tex - Old peptides with new faces: A new strategy to develop non-toxic antimicrobial textiles for healthcare applications [PTDC/EBB-BIO/113671/20099
Inverse Problems, Eigenvalues Multiplicities and Graphs [PTDC/MAT/112273/2009]
DES-ZYME: Biocatalytic separation of enantiomers using Natural Deep Eutectic Solvents [PTDC/BBB-EBB/1676/2014]
Innovative therapies and technologies in cancer
Bolsa de Pós-Doutoramento FCT: Purification, detection and stabilization of G-quadruplex for cancer therapy [SFRH/BPD/100015/2014]
Drug repurposing from cancer therapy to control of infections [PTDC/BIA-MIC/5343/2020]
Nonlinear Hyperbolic Systems: Theory and Numerical Approximation [PTDC/MAT/110613/2009]
CONTRIBUTION FOR THE UNDERSTANDING OF THE BIOLOGICAL ROLE OF CHLAMYDIA TRACHOMATIS PLASMID
My Clock, my Therapy: the role of Circadian Rhythm in Cancer Therapy
BioM2D: BioMaterials Molecular Dynamics for biopharmaceutical purification – feasibility study using HPC
TARGETING SIGNALING PATHWAYS AS THERAPY FOR HUMAN CANCER
Stratus: A Layered Approach to Data Management in the Cloud [PTDC/EIA-CCO/115570/2009]
Smart porous particles for pulmonary drug and vaccine delivery [PTDC/EQU-EQU/116097/2009]
New Extraction Processes for the Purification of Monoclonal Antibodies using Bio-inspired Ionic Liquids
The use of Methylated DNA Immunoprecipitation MeDIP in cancer for better clinical management
Opportunistic Aggregation of Spectrum and Cognitive Radios: Consequences on Public Policies [PTDC/EEA-TEL/115981/2009]
CANCER THERAGNOSTICS - MULTIFUNCTIONAL GOLD NANOPARTICLES FOR DIAGNOSTICS AND THERAPY
Liposomes encapsulating catechins: a way to cancer therapy
Comparing pediatric and adult cancer progression and therapy response
Bolsa de Pós-Doutoramento FCT: Platform for the biosynthesis and purification of HPV-16 E6/E7mutant DNA vaccine for cervical cancer treatment or prevention [SFRH/BPD/102716/2014]
ERADICATION OF HIV-1 INFECTED CELLS BY TARGETING NANOPARTICLES CARRYING THERAPEUTIC PLASMIDS
RATIONAL ENGINEERING OF E. COLI STRAINS AND VECTORS FOR IMPROVED MANUFACTURING OF PLASMID BIOPHARMACEUTICALS
Genetic and chronological characterisation of the European settlement by modern humans in the Upper Palaeolithic [PTDC/CS-ANT/113832/2009]
ISOLATION, CHARACTERIZATION, VIRULENCE FACTORS AND ANTIBIOTIC RESISTANCE AMONG CAMPYLOBACTER SPP. ISOLATED FROM FOOD AND CLINICAL CASES
MODULATION OF BASE EXCISION REPAIR PATHWAY FOR BREAST CANCER THERAPY
Nucleolin targeting by G-quadruplex aptamers for cervical cancer therapy
Publicações relacionadas
Carregando publicações...